Previous close | 6.20 |
Open | 5.22 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 5.22 - 5.22 |
52-week range | 5.22 - 10.76 |
Volume | |
Avg. volume | 1 |
Market cap | 651.477M |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | 18.64 |
EPS (TTM) | 0.28 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | 0.13 (2.47%) |
Ex-dividend date | 27 Sept 2024 |
1y target est | N/A |
HYOGO, Japan, March 19, 2024--JCR Pharmaceuticals announces achievement of milestone using J-Brain Cargo® for neurodegenerative disease in research collaboration with Alexion.
HYOGO, Japan, February 29, 2024--JCR Pharmaceuticals celebrates Rare Disease Day 2024 and highlights its commitment to the rare disease community.
HYOGO, Japan, February 14, 2024--JCR announced the presentation of several datasets demonstrating the potential benefits of its investigational LSD therapies at the WORLDSymposium™.